Convalescent plasma trial prompts treatment optimism

A U.S. study has found using plasma from COVID-19 survivors' blood
could be an effective way to treat patients to lessen the severity of
the virus.

The first study of its kind on convalescent plasma is expected to lead
to clinical trials.

Nick Harper reports.

IN: "Researchers at...."
OUT: SOC
DUR: 38 seconds

http://www.fsnradionews.com/feeds/0514plasma-nh.mp3